Atlas Trials

Phase I Trial of Vandetanib Combined With 131I-mIBG to Treat Patients With Advanced Phaeochromocytoma and Paraganglioma

Clinical trial NCT01941849 · WITHDRAWN

Trial details

NCT number
NCT01941849
Sponsor
University College, London
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
PhaeochromocytomaParaganglioma
Start date
2014-10-01
Primary completion
2015-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.